Advertisement
A glimpse into surgical decision-making in a singular case
Insights from the first-ever use of HoloLens in face transplantation
An increasingly viable option for selected patients
Organs from overdose-death donors are as good as any others
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Will use machine learning and more to gauge survival disparities
New potent immunosuppression requires careful pretransplant assessment, posttransplant care
Waiting-list considerations: organs are scarce
Response to locoregional therapy helps predict tumor behavior and transplant success
Effective HCV treatments enable transplantation of HCV-positive organs to HCV-negative patients
Clinical trial will take place near the end of 2018
Advertisement
Advertisement